Scandion Oncology
Overcoming cancer drug resistance

Navbar

About us
Research & Development
Press releases
Investors & Media
Contact
- Career
- Business development

Skip to content

3 February 2020

CEO Presentation from Aktiespararna Investor Day

CEO Nils Brünner presented at Aktispararna Investor meeting on January, 28th, 2020.

The presentation can be viewed here.

Posted in NewsTagged News

Post navigation

CEO Nils Brünner will present at the Life Science Investor conference held by Økonomisk Ugebrev

Correction of dates for public information on Estimated Primary Completion and Primary Study Completion for a Clinical Phase II study

Information types

Choose your information types.

Annual Financial Statement

Annual report / Annual accounts

Company Announcement / Press release

Interim Report

Invitation

Newsletter

Stay updated with news from Scandion Oncology

Subscribe below

Subscription successful. To activate the subscription, we request that you confirm your e-mail address. Do this by clicking on this link in the email we just sent you.

Subscription failed. Error:

Yes, I would like to receive information from Scandion Oncology in accordance with the privacy policy.

Frontpage
Press releases
CEO Presentation from Aktiespararna Investor Day

About us

About us
Executive Management
Board of Directors
Clinical Advisory Board

Research & Development

Research & Development
Pipeline
Clinical Development
Science
Patents

Investors & Media

Investors & Media
Share information
Financial Reports
Presentations
Media
Analyst Coverage
Prospectuses
Corporate governance
Events

Contact us

Scandion Oncology A/S
Symbion
Fruebjergvej 3
2100 Copenhagen
Denmark

Phone: +45 38 10 20 17
info@scandiononcology.com

Media and Investor relations:
Email: ir@scandiononcology.com
Phone: +45 29 60 35 32

Follow us

Scandion Oncology - The Cancer Drug Resistance Company

Our vision is to overcome cancer drug resistance in order to improve lives for cancer patients and their families

© Copyright 2022 - Scandion Oncology A/S | We use cookies to improve our services | Cookie settings | Disclaimer: Market data could be delayed. Delivered by Cision.

Cookies

We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings". Read our cookie policy

Settings Accept all

Cookies

Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy

Necessary
These cookies are not optional. They are needed for the website to function.
Statistics
In order for us to improve the website's functionality and structure, based on how the website is used.
Experience
In order for our website to perform as well as possible during your visit. If you refuse these cookies, some functionality will disappear from the website.
Marketing
By sharing your interests and behavior as you visit our site, you increase the chance of seeing personalized content and offers.

Save Accept all